Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation.

MLA

Tanimoto, Koichi, et al. “Fluoroquinolone Enhances the Mutation Frequency for Meropenem-Selected Carbapenem Resistance in Pseudomonas Aeruginosa, but Use of the High-Potency Drug Doripenem Inhibits Mutant Formation.” Antimicrobial Agents and Chemotherapy, vol. 52, no. 10, Oct. 2008, pp. 3795–800. EBSCOhost, https://doi.org/10.1128/AAC.00464-08.

APA

Tanimoto, K., Tomita, H., Fujimoto, S., Okuzumi, K., & Ike, Y. (2008). Fluoroquinolone enhances the mutation frequency for meropenem-selected carbapenem resistance in Pseudomonas aeruginosa, but use of the high-potency drug doripenem inhibits mutant formation. Antimicrobial Agents and Chemotherapy, 52(10), 3795–3800. https://doi.org/10.1128/AAC.00464-08

Chicago

Tanimoto, Koichi, Haruyoshi Tomita, Shuhei Fujimoto, Katsuko Okuzumi, and Yasuyoshi Ike. 2008. “Fluoroquinolone Enhances the Mutation Frequency for Meropenem-Selected Carbapenem Resistance in Pseudomonas Aeruginosa, but Use of the High-Potency Drug Doripenem Inhibits Mutant Formation.” Antimicrobial Agents and Chemotherapy 52 (10): 3795–3800. doi:10.1128/AAC.00464-08.